Stay updated on Tisotumab Vedotin Safety in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Tisotumab Vedotin Safety in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tisotumab Vedotin Safety in Solid Tumors Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    New study locations were added across several regions, including Texas (USA), Brussels Capital, Flemish Brabant, Hainaut, Liège, and Namur in Belgium, Győr-Moson-Sopron and Hajdú-Bihar in Hungary, and England. Some previous location groupings were removed, and the study page revision updated from v3.3.2 to v3.3.3; the HHS Vulnerability Disclosure link was removed.
    Difference
    0.8%
    Check dated 2025-12-22T22:39:04.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision notes show a new version: v3.3.2 added and v3.3.1 removed; no changes to the visible study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T15:43:03.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Publication listing description updated to say entries are automatically filled from PubMed, and a Revision: v3.3.1 tag was added.
    Difference
    0.1%
    Check dated 2025-11-24T12:16:21.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    Notice about potential delays due to government funding was removed from the page.
    Difference
    0.3%
    Check dated 2025-11-17T06:19:06.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    No significant additions or deletions were detected on the Study Details page; the content and structure appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T00:54:51.000Z thumbnail image
  9. Check
    85 days ago
    Change Detected
    Summary
    Added a new technical reference on exposure-safety modeling for ocular adverse events related to tisotumab vedotin; no deletions observed.
    Difference
    0.7%
    Check dated 2025-10-12T13:59:17.000Z thumbnail image

Stay in the know with updates to Tisotumab Vedotin Safety in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tisotumab Vedotin Safety in Solid Tumors Clinical Trial page.